This year’s spring cohort for the gBETA Madison startup accelerator includes companies developing at-home health tests, manufacturing technologies, health care operations software and more.
Organizers for the program recently announced the five startup companies chosen for the free, seven-week experience, which aims to prepare entrepreneurs for participating in equity-based accelerators and seeking investment capital.
Participants will pitch to investors and members of the public during an April 28th showcase event in Madison to cap off the program, which is organized by gener8tor and also involves WEDC.
The spring 2026 cohort includes:
*3D Powder Tech, which has technology for accurately measuring the spreadability of powder feedstock material used in metal additive manufacturing.
Its solutions aim to “improve reliability, consistency, and quality” for 3D printing used in industrial applications such as aerospace, biomedical and automotive. The Madison company has raised $155,000 in pre-seed non-dilutive funds to develop a prototype and identify potential customers.
*Doogooda, a startup with an automation platform for operational decision-making in health care, such as staffing, policy updates and more. The Korean company points to a lack of documentation for decisions across these areas, resulting in “decision fatigue” among leadership and “zero audit trail” for justifying decisions to regulators or board.
The company says it’s generated $500,000 in revenue from at least five institutional clients in hospitals, government and other businesses. Founders are looking to leverage initial momentum in Korea’s single-payer health care system to enter the U.S. market.
*FerroMX, which is developing a “next-generation energy storage” system, promising safer and longer-lasting metal ion batteries.
The Madison-based business has done more than 150 customer discovery interviews with battery manufacturers and others in the industry, and has raised $50,000 in non-dilutive funding for further market development of its patented technology.
*HCL, a company with “mineral-based soil technologies” to help farmers improve fertilizer efficiency and water retention while lowering costs and environmental impacts.
With $150,000 in initial annual revenue, the Columbian company is seeking to break into the U.S. market.
*Nelambos, another Madison-based startup that’s developing an at-home self-administered diagnostic test for urinary tract infections. It can be used by patients or caregivers to detect UTIs earlier, with a goal of preventing further bloodstream infections and sepsis and reducing health care costs.
Company leaders have filed a patent application for its test, and have completed at least 250 customer interviews to gauge the market.
Since it began in 2015, graduates of the gBETA program have raised more than $1 billion in capital and created at least 7,000 jobs across the United States and Canada, according to figures from gener8tor.
See more in the release.
